Variables | HL N = 33 | NHL N = 17 |
---|---|---|
Age (Mean ± SD) | 10.5 ± 4.5 | 8.1 ± 4.6 |
Sex | Â | Â |
Male: n = 32 | 18 | 14 |
Female: n = 18 | 15 | 3 |
M:F ratio | 1:2:1 | 4:6:1 |
LFT (Mean ± SD) |  |  |
ALT (IU/L) | 25.2 ± 11.7 | 29.2 ± 12.7 |
AST (IU/L) | 21.2 ± 11.4 | 21.7 ± 9.9 |
T. Bil (mg/dL) | 1.1 ± 0.3 | 1.0 ± 0.4 |
KFT (Mean ± SD) |  |  |
Creatinine (mg/dL) | 0.9 ± 0.3 | 1.0 ± 0.3 |
CBC (Mean ± SD) |  |  |
Hb (g/dL) | 10.6 ± 2.2 | 7.6 ± 3.0 |
TLC (×109/l) | 5.3 ± 3.6 | 2.9 ± 4.6 |
Plt (×109/l) | 134.9 ± 79.1 | 171.3 ± 208.4 |
ANC (×109/l) | 1.8 ± 1.3 | 1.4 ± 2.3 |
Mono (×109/l) | 1.5 ± 1.2 | 0.6 ± 1.0 |
LDH (Mean ± SD) (IU/L) | 207.4 ± 214.2 | 443.7 ± 667.5 |
ESR 1 st hr (Mean ± SD) | 40.5 ± 31.1 | 35.4 ± 24.5 |
ESR 2 nd hr (Mean ± SD) | 73.5 ± 63.7 | 65.1 ± 45.9 |
Phase of therapy | Â | Â |
Induction: n = 24 | 15 | 9 |
Post-induction: n = 23 | 16 | 7 |
Salvage: n = 3 | 2 | 1 |
Stage of disease | Â | Â |
I+II (n = 25) | 19 | 6 |
III+IV (n = 25) | 14 | 11 |